Cross Country Healthcare, Inc.
NASDAQ:CCRNMedical - Care Facilities
+$0.01 today
- Market cap
- $428.06M
- Beta
- 0.45
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.13
Volume 1.78M
Average 0.64M
CCRN Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Cross Country Healthcare, Inc.NASDAQ: CCRN
Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Free cash flow declines year over year
Q1 FY2026 free cash flow of $3.31M fell 12.8% year over year, ahead of the -64.4% change in trailing-twelve-month free cash flow. Sequentially, it fell 79.5% from the prior quarter. Over 3 fiscal years it compounded at -31.6% a year.
Context
- Free cash flow amounted to 3.8% of revenue in FY2025, down 4.5 pp from a year earlier.
- Free cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -12.8% holds above the trailing-twelve-month pace of -64.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 40.09M USD
- Year-over-year change
- -64.0%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 40.09M | -64.0% |
| FY2024 | 2024-12-31 | 111.4M | -52.5% |
| FY2023 | 2023-12-31 | 234.52M | +87.2% |
| FY2022 | 2022-12-31 | 125.26M | +235.0% |
| FY2021 | 2021-12-31 | (92.79M) | — |
Free Cash Flow vs competitors
How CCRN compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -64.4% is the 8th highest of 9, against a peer median of +30.3%.
- Free cash flow amounts to 4.0% of revenue for CCRN, versus a peer median of 8.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
AUNAAuna S.A. | LTM Mar 2026 | PEN 492.83M PEN | +4.4% | +147.5% | 10.9% |
| LTM Mar 2026 | $76.61M USD | +26.2% | -10.0% | 1.3% | |
| LTM Mar 2026 | $47.05M USD | +117.8% | -31.0% | 11.4% | |
| LTM Mar 2026 | $39.6M USD | -64.4% | -31.6% | 4.0% | |
| LTM Mar 2026 | $25.97M USD | -29.7% | -13.5% | 12.5% | |
| LTM Mar 2026 | $25.73M USD | +34.3% | -25.5% | 4.7% | |
| LTM Mar 2026 | $14.33M USD | +127.1% | +21.5% | 13.4% | |
| LTM Mar 2026 | $12.63M USD | -65.8% | -20.5% | 5.2% | |
MCTACharming Medical Limited Class A Ordinary Shares | FY2024 | $138.36K USD | +63.1% | — | 2.2% |
| Peer median (excluding CCRN) | — | +30.3% | -13.5% | 8.0% | |
Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 132M | 185.98M | 72.63M | (14.56M) | (94.85M) |
| Depreciation & Amortization | 9.85M | 12.58M | 18.35M | 18.2M | 16.79M |
| Deferred Income Tax | (9.93M) | 5.11M | 1.3M | (1.94M) | 10.07M |
| Stock-Based Compensation | 6.89M | 7.39M | 6.58M | 6.03M | 7.14M |
| Change in Working Capital | (237.26M) | (103.71M) | 127.48M | 87.63M | 30.47M |
| Accounts Receivables | (318.42M) | (153.23M) | 251.43M | 128.33M | 56.73M |
| Inventory | (83.29M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 83.29M | 0 | (126.61M) | (29.75M) | 0 |
| Other Working Capital | 81.16M | 49.52M | 2.66M | (10.95M) | (26.26M) |
| Other Non-Cash Items | 12.82M | 26.7M | 22.16M | 24.77M | 78.63M |
| Operating Cash Flow | (85.62M) | 134.05M | 248.5M | 120.12M | 48.25M |
| Capital Expenditures | (7.17M) | (8.79M) | (13.97M) | (8.71M) | (8.16M) |
| Acquisitions (Net) | (26.88M) | (35.09M) | 199K | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (34.05M) | (43.87M) | (13.78M) | (8.71M) | (8.16M) |
| Debt Repayment | 127.68M | 32.34M | (150.68M) | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (2.23M) | (35.29M) | (57.65M) | (37.31M) | (6.83M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (6.35M) | (84.65M) | (12.91M) | (9.54M) | (6.17M) |
| Financing Cash Flow | 119.09M | (87.6M) | (221.24M) | (46.85M) | (13.01M) |
| Effect of Forex Changes | 6K | (9K) | 8K | (14K) | 21K |
| Net Change in Cash | (564K) | 2.57M | 13.49M | 64.54M | 27.11M |
| Free Cash Flow | (92.79M) | 125.26M | 234.52M | 111.4M | 40.09M |
Cross Country Healthcare, Inc.
NASDAQ:CCRN
Intrinsic Alpha fair value
Locked
Current Price
$13.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.